HOME >> BIOLOGY >> NEWS
Major Wellcome Trust award to take science from the bench to the bedside

Clinicians and scientists studying how a variety of human diseases arise have received a major boost today. The Cambridge Institute for Medical Research, University of Cambridge, where researchers look at the underlying molecular and cellular mechanisms behind disease, has been awarded one of the prestigious Wellcome Trust Strategic Awards. The 4 million grant will enable the CIMR to stay at the leading edge of research into how diseases arise and to play a key role training tomorrows academic doctors and medical scientists.

The Institute is a multidisciplinary research centre whose outstanding feature is the interweaving of clinical medicine with molecular and cell biology. Since it opened in 1998, it has led key research into how viruses evade our immune system, genetic susceptibility to diabetes and progress towards novel treatments for Alzheimer's and Huntington's disease.

"What we are striving to provide in CIMR is an effective interface between basic and clinical science to underpin our goal of determining and understanding the molecular mechanisms of disease," says Professor Paul Luzio, Director of CIMR. "With the support of the Wellcome Trust we have attracted outstanding basic and clinical scientists to the Institute. The Strategic Award will underpin our scientific infrastructure, help us bring scientifically trained clinicians back into research after their specialist clinical training.

"Our Institute is not disease-specific but our focus over the next few years will provide insights into the molecular pathology of many diseases and help to identify novel therapeutic targets. CIMR will continue to be a great place to work for those whose primary interests are focused on disease and for some who are more interested in basic cellular mechanisms which, when they malfunction, result in disease. "

As well as facilitating collaboration between clinicians and basic scientists, the Institute also aims to play a key role
'"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
30-Nov-2006


Page: 1 2

Related biology news :

1. Major breakthrough in understanding how HIV interferes with infected cell division
2. Major study predicts grim future for Europes seas
3. Major genetic study identifies clearest link yet to obesity risk
4. Major gene study uncovers secrets of leukemia
5. Major society publisher announces support for public access to scientific literature
6. Major link in brain-obesity puzzle found
7. Major breakthrough in the mechanism of myelin formation
8. Major new osteoporosis study to recruit people in Orkney
9. Major genetic risk factor found for prostate cancer
10. Major report on tigers to be released Thursday at National Zoo
11. Major initiative proposed to address amphibian crisis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... antibody development services, today announced that the company has received ISO9001:2015 certification ... pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku Corporation , ... event in a series of TOPIQ webinars, which will cover the Transferable Aspherical ... developed in response to social distancing measures that resulted in postponements and cancelations ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... for Data Decisions,” for pharmaceutical and biotech executives, laboratory managers, scientists, researchers ... scientific instruments and laboratory equipment from dozens of manufacturers into their lab. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
(Date:7/31/2020)... ... , ... eSource has long been touted as the solution to high data ... the reasons it did not take off as quickly as people initially expected, and ... moving towards capturing data electronically for clinical trials and then repurposing it for downstream ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining ... research team led by Dr MA has been using the zebrafish model to ...
Breaking Biology Technology:
Cached News: